Cargando…
Development of aptamer-based inhibitors for CRISPR/Cas system
The occurrence of accidental mutations or deletions caused by genome editing with CRISPR/Cas9 system remains a critical unsolved problem of the technology. Blocking excess or prolonged Cas9 activity in cells is considered as one means of solving this problem. Here, we report the development of an in...
Autores principales: | Zhao, Jing, Inomata, Rika, Kato, Yoshio, Miyagishi, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897479/ https://www.ncbi.nlm.nih.gov/pubmed/33123724 http://dx.doi.org/10.1093/nar/gkaa865 |
Ejemplares similares
-
Repurposing the CRISPR-Cas9 system for targeted DNA methylation
por: Vojta, Aleksandar, et al.
Publicado: (2016) -
Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system
por: Josipović, Goran, et al.
Publicado: (2019) -
Genome-wide CRISPR/Cas9 transcriptional activation screen identifies a histone acetyltransferase inhibitor complex as a regulator of HIV-1 integration
por: Zhang, Qiong, et al.
Publicado: (2022) -
Type I CRISPR-Cas provides robust immunity but incomplete attenuation of phage-induced cellular stress
por: Malone, Lucia M, et al.
Publicado: (2021) -
Functional validation of mouse tyrosinase non-coding regulatory DNA elements by CRISPR–Cas9-mediated mutagenesis
por: Seruggia, Davide, et al.
Publicado: (2015)